| Symbol | TLX |
|---|---|
| Name | TELIX PHARMACEUTICALS LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 55 FLEMINGTON ROAD, NORTH MELBOURNE, C3 3051 |
| Telephone | 61 3 9093 3855 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002007191 |
| Description | None |
New Form 3 - Telix Pharmaceuticals Ltd <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001628280-26-036099 <b>Size:</b> 468 KB
Read moreNew Form 3 - Telix Pharmaceuticals Ltd <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001628280-26-036098 <b>Size:</b> 469 KB
Read moreNew Form 3 - Telix Pharmaceuticals Ltd <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001628280-26-036096 <b>Size:</b> 468 KB
Read moreDirector Behrenbruch Christian 🟢 acquired 67.9K shares of Telix Pharmaceuticals Ltd (TLX) at $14.87 Transaction Date: Apr 28, 2026 | Filing ID: 031608
Read moreTelix Successfully Prices and Upsizes US$600 Million Convertible Bonds USA - English …
Read more